Case Background:
This is a class action lawsuit on behalf of those who purchased or acquired Ginkgo Bioworks Holdings, Inc. (“Ginkgo”) (NYSE: DNA) f/k/a Soaring Eagle Acquisition Corp. (“Soaring Eagle”) (NASDAQ: SRNG) securities between May 11, 2021 and October 5, 2021, inclusive (the “Class Period”).
The complaint alleges that throughout the Class Period, the Defendants failed to disclose that Ginkgo’s failure to derive real revenue from third-party customers left it almost completely dependent on related parties that Ginkgo created or controlled through its ownership and board seats.
Current Status of Case:
On December 13, 2024, the Court granted Final Approval of the Class Action Settlement. This action has concluded.
The deadline to file a claim is November 21, 2024. If you have any questions or need further information about this settlement, you may go to the following website www.GinkgoSecuritiesSettlement.com, or you can contact the claims administrator, Strategic Claims Services, at 1-866-274-4004.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com.